“New Lab Here Would Study Monkeypox”

Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

Researchers from St. Louis University (SLU), Washington University in St. Louis, and Case Western University in Cleveland are seeking a National Institutes of Health grant to build a biosafety level three facility at SLU. The lab would have the second-highest level of protection from dangerous organisms; level four labs have the most protection. According to Robert Webster, associate provost for research at the SLU Health Sciences Center, SLU has three level three labs already, while Washington University has nine; however, none of the labs have “select agents,” which are bacteria, viruses, or toxins that could be used as possible bioterror weapons. The new facility, which would be called the Midwest Regional Biocontainment Laboratory, would research vaccines and drugs to fight select agents that could be spread by natural or intentional means, such as anthrax, plague-causing bacteria, or monkeypox.

Return to Vaccination News Home Page

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.